American Society of Hirudotherapy

Linda K.

Chronic Venous Insufficiency with Venous Ulcer

58 · Portland, Oregon2024–202514Medical records reviewed
Venous Ulcer (CVI)Chronic Wound Management

As a nurse, I thought I knew everything about wound care. But when I developed my own venous ulcer that wouldn't heal, I realized how little I understood about what patients really go through. Leech therapy was the missing piece that finally got my wound to close after eight months of frustration.

Linda K.

Linda K., a 58-year-old registered nurse from Portland, Oregon, shares her experience living with severe chronic venous insufficiency (CVI) and how leech therapy helped heal a persistent venous ulcer when standard treatments failed.

Background: A Nurse's Health Journey

Linda worked as an ICU nurse for nearly three decades. Prolonged standing, heavy lifting, and family history of venous disease led to CVI diagnosis in 2016. Despite compression stockings, leg elevation, weight loss (25 lbs), and walking programs, her disease kept progressing. By 2020, she had developed lipodermatosclerosis.

The compression stockings helped, but they were uncomfortable and hot. I was compliant, but my disease kept progressing. By 2020, I had developed lipodermatosclerosis — that hard, leathery skin around my ankles. I knew I was heading toward ulcers.

patient-stories.stories.cvi-venous-ulcer.sections.background.quoteAttribution

patient-stories.stories.cvi-venous-ulcer.sections.treatment.title

patient-stories.stories.cvi-venous-ulcer.sections.treatment.content

patient-stories.stories.cvi-venous-ulcer.sections.treatment.quote

patient-stories.stories.cvi-venous-ulcer.sections.treatment.quoteAttribution

patient-stories.stories.cvi-venous-ulcer.sections.experience.title

patient-stories.stories.cvi-venous-ulcer.sections.experience.content

patient-stories.stories.cvi-venous-ulcer.sections.experience.quote

patient-stories.stories.cvi-venous-ulcer.sections.experience.quoteAttribution

patient-stories.stories.cvi-venous-ulcer.sections.challenges.title

patient-stories.stories.cvi-venous-ulcer.sections.challenges.content

patient-stories.stories.cvi-venous-ulcer.sections.challenges.quote

patient-stories.stories.cvi-venous-ulcer.sections.challenges.quoteAttribution

patient-stories.stories.cvi-venous-ulcer.sections.outcomes.title

patient-stories.stories.cvi-venous-ulcer.sections.outcomes.content

patient-stories.stories.cvi-venous-ulcer.sections.outcomes.quote

patient-stories.stories.cvi-venous-ulcer.sections.outcomes.quoteAttribution

patient-stories.stories.cvi-venous-ulcer.sections.reflections.title

patient-stories.stories.cvi-venous-ulcer.sections.reflections.content

patient-stories.stories.cvi-venous-ulcer.sections.reflections.quote

patient-stories.stories.cvi-venous-ulcer.sections.reflections.quoteAttribution

Key Outcomes

Wound 80% reduced in 4 weeks
Complete healing in 5 weeks (after 8 months failed standard care)
14 months ulcer-free
Returned to part-time nursing
Cost-effective vs. continued wound care
patient-stories.stories.cvi-venous-ulcer.keyOutcomes.5

Medical Perspective

Treating Physician

Dr. Raj Patel, MD

Physical Medicine & Rehabilitation, Wound Care

Linda's case exemplifies appropriate use of leech therapy as adjunctive treatment for refractory venous ulcer. The 80% wound size reduction in 4 weeks significantly exceeded typical healing rates with standard care alone. Key success factors: adequate arterial circulation (ABI >1.0), failed 4+ months standard care, compliant patient, and proper technique with periwound application.

Medical Disclaimer

Individual results vary. These stories represent personal experiences and are not guarantees of outcome. Leech therapy requires proper medical supervision. Consult a qualified healthcare provider before starting any treatment.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.